Newsfiscal.ai
HeartBeam Receives FDA Clearance for Acute Myocardial Infarction Assessment Technology
· Published
Article summary
HeartBeam, Inc. has received U.S. Food and Drug Administration (FDA) clearance for its technology designed to assess acute myocardial infarction.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…